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Th2 Cytokines Act on S100/A11 to Downregulate
Keratinocyte Differentiation
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Jasmina S. Redzic3, Kirk C. Hansen3 and Donald Y.M. Leung1,2
Atopic dermatitis (AD) is an inflammatory skin disease associated with frequent skin infection and impaired skin
barrier function. Recent studies indicate that increased Th2 cytokine expression contributes to reduction in
antimicrobial peptides and reduced filaggrin (FLG) expression, however, the mechanisms leading to this effect
is unknown. Using proteomics, we found the S100 calcium-binding protein A11 (S100/A11) to be significantly
downregulated in the presence of IL-4 and IL-13. Culturing keratinocytes with increased calcium concentrations
significantly induced S100/A11 expression. This corresponded with an increase in human b-defensin (HBD)-3
and FLG expression. Interference of S100/A11 expression, by siRNA, inhibited induction of HBD-3 and FLG.
Furthermore p21, a cyclin-dependent kinase inhibitor downstream of S100/A11, was required for calcium-
mediated induction of HBD-3 and FLG. Importantly, transduction of p21-recombinant protein into keratinocytes
prevented IL-4/IL-13-mediated inhibition of FLG and HBD-3 expression. S100/A11 and p21 gene expression was
also found to be significantly lower in acute and chronic AD skin. This study demonstrates an important role for
S100/A11 and p21 in regulating skin barrier integrity and the innate immune response.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin
disorder that affects nearly 17% of children, and can
significantly compromise their quality of life (Leung et al.,
2004; Zuberbier et al., 2006). Management of this illness is
complicated by frequent skin infections, including a propen-
sity toward Staphylococcus aureus infection, eczema herpe-
ticum, and eczema vaccinatum. Recent genetic studies have
highlighted the importance of skin barrier defects as loss-of-
function (null) mutations in skin barrier genes encoding
filaggrin (FLG) are associated with severe AD and develop-
ment of asthma in AD patients (Morar et al., 2006; Palmer
et al., 2006; Weidinger et al., 2006; Sandilands et al., 2007).
These observations are consistent with animal model studies
of AD demonstrating that a defective skin barrier enhances
allergen sensitization, leading to systemic allergic responses
such as increased IgE levels and airway hyper-reactivity
(Spergel et al., 1998). Of note, the FLG-null mutation is
observed in less than one-third of the general AD population
and most patients outgrow AD (Leung et al., 2004; Palmer
et al., 2006). Since most AD patients have a defective skin
barrier, which responds to anti-inflammatory therapy, this
suggests there are non-genetic mechanisms, which modulate
skin FLG expression (Sugiura et al., 2005; Cork et al., 2006).
Indeed, we have recently observed that skin FLG expression
can be downregulated by the Th2 cytokines, IL-4 and IL-13
(Howell et al., 2007a).
The increased susceptibility of these patients to recurrent
bacterial and viral skin infections has been linked to an
acquired deficiency of antimicrobial peptides in the epider-
mis of AD (Ong et al., 2002; Howell et al., 2006a, b). Acute
AD skin is characterized by the over-expression of interleukin
(IL)-4 and IL-13 (Hamid et al., 1994; Homey et al., 2006).
These Th2 cytokines are known not only to induce allergic
responses, but to downregulate innate immune response
genes in the skin (Nomura et al., 2003a, b). The mechanism
by which IL-4 and IL-13 inhibits FLG and human b-defensin
expression (HBD) in keratinocytes is unknown. Our current
study used a hypothesis-free proteomics approach to identify
novel proteins involved in the effects of IL-4 and IL-13 on
human keratinocyte differentiation. Our data identify the
S100 calcium-binding protein A11 (S100/A11) as a target in
Th2 cytokine-mediated inhibition of FLG and the antimicro-
bial peptides, HBD-3, expression in AD.
RESULTS
Proteomic identification of proteins in keratinocytes modulated
by IL-4 and IL-13
Proteomics was used to investigate the effect of IL-4 and IL-13
stimulation on protein expression in the HaCaT keratinocyte
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cell line. Initial protein targets were identified using two-
dimensional gel electrophoresis that incorporates differential
fluorescent labeling (Unlu et al., 1997). Overall, 2,627 spots
were detected on the gel; 722 of which were excluded due to
extremely low intensity, having a high slope (that is, dust
particles), or being on the peripheral edges of the gel. Based
on the initial gels, we targeted protein spots with an
approximately twofold absolute difference between the two
samples. Comparison of the two cell states was performed in
triplicate and the percentage of protein spots with an absolute
value of approximately twofold difference was consistent
among the three gels.
Protein spots were picked from the gel, digested with
trypsin, and subjected to peptide mass fingerprinting for
protein identification. The spots chosen for excision were
based on spot volume/intensity, consistency of fold change,
position on the gel and proximity to other ‘picked’ spots (that
is, to avoid overlap). Preparative gels were stained with the
total protein stain Deep Purple to assess the presence of any
mass shifts between labeled and unlabeled protein and to
determine the feasibility of mass spectrometry-based identi-
fication. This was performed since mass shifts can occur with
low molecular weight proteins and cyanine dye (CyDye)
expression does not always correspond with protein abun-
dance, respectively (Hrebicek et al., 2007). Based on this
selection criteria, nine protein spots were picked for
identification using mass spectrometry (Figure 1a and b).
Within this set of 9 spots, six resulted in statistically
significant (Po0.01) identifications based on a low prob-
ability value that the identified protein is a random event. Of
these, a total of five unique proteins were identified from six
spots on the gel (Table 1). These proteins were sorted based
on the percentage of mass spectrometry ‘‘visible’’ sequence
coverage. This is different than the total sequence coverage,
in that it does not include tryptic peptides below 500Da or
above 5,000Da as these are the mass cutoffs for data
acquisition. Most low- (o500Da) and high- (45,000Da)
mass peptides are difficult or impossible to detect at the
abundances found in gel spots due to matrix clusters
dominating the low mass region of the Matrix-Assisted Laser
Desorption/Ionization Time-of-Flight spectra and a drastic
drop off of sensitivity for higher masses.
IL-4 and IL-13 downregulate S100/A11
Due to the high percentage of mass spectrometry coverage
(Table 1), and previous literature suggesting an important role
for the S100 protein family in epidermal function (Nomura
et al., 2003b), we further investigated S100/A11, a member of
the S100 family that has not been previously implicated in
AD or cytokine modulation. Using real-time reverse tran-
scriptase-PCR (RT-PCR) and immunoblotting, we rigorously
investigated the modulation of S100/A11 gene and protein
expression, respectively, by IL-4 and IL-13. HaCaT cells
stimulated with IL-4 and IL-13 expressed significantly lower
levels of S100/A11 mRNA (1.82±0.17 ng S100/A11 per
nanogram of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH); Po0.001) as compared with cells treated with
media alone (3.93±0.23). Furthermore, treatment with high
CaCl2 (10mM) significantly induced S100/A11 expression
(10.04±0.28; Po0.001) in HaCaT cells as compared with
lower CaCl2 (1.5mM) (3.93±0.23). This induction was
significantly inhibited by IL-4 and IL-13 (2.27±0.37) (Figure
2a). This observation was confirmed at the protein level using
immunoblotting (Figure 2b). HaCaT cells are an immortalized
keratinocyte cell line; therefore we also investigated normal
primary human keratinocytes (NHK). Similar to HaCaT cells,
high CaCl2 (1.3mM) significantly (Po0.001) induced S100/
A11 gene expression in NHK (Figure 2c). This induction was
similarly inhibited by IL-4 and IL-13 treatment.
Deficiency of S100/A11 in acute and chronic AD skin
To determine whether levels of S100/A11 mirrored known
cytokine changes found in human allergic skin disease, we
examined skin biopsies from acute AD (previously reported
to be associated with increased IL-4 and IL-13) versus chronic
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Figure 1. Proteomic analysis of keratinocytes treated with IL-4 and IL-13.
(a) Proteomics. Analytical two-dimensional gels showing proteins upregulated
(green) or downregulated (red) by IL-4 and IL-13 in the HaCaT keratinocyte
cell line. Spot numbers compared to the ‘‘master column’’ in Table 1.
(b) Histogram of the S100/A11 spot on the analytical gel. Spot no. 2,705
was excised from the two-dimensional gel and digested with trypsin. The
digest solution was spotted with matrix and analyzed by mass
spectometry.
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AD (associated with combination of Th1 and Th2 cytokines)
and psoriasis (associated with increased Th1 cytokines).
Using real-time RT-PCR, we found that S100/A11 gene
expression is significantly decreased in acute AD
(0.58±0.05 ng S100/A11 per nanogram of GAPDH;
Po0.001) and chronic AD (1.14±0.20; Po0.001), as
compared to skin from normal subjects (6.68±0.51) or
psoriasis patients (6.86±0.46) (Figure 3a). This was con-
firmed at the protein level using immunostaining (Figure 3b).
The composite data for S100/A11 immunostaining is shown
in Figure 3c.
Role for S100/A11 in keratinocyte differentiation and host
defense
S100 proteins play an important role in calcium-dependent
cellular processes (Unlu et al., 1997). We therefore investi-
gated the role of S100/A11 in calcium-driven keratinocyte
differentiation and the induction of the antimicrobial peptide
HBD-3. In HaCaT cells, we demonstrate that increased
CaCl2 (10mM) induces the expression of both HBD-3
(5.19±0.49 ng HBD-3 per nanogram of GAPDH; Po0.001)
and FLG (0.015±0.002 ng FLG per nanogram of GAPDH;
Po0.001) as compared to low CaCl2 (1.5mM) (HBD-3:
Table 1. Mass spectrometry data for all the significant spots with greater than twofold change on the preparative
gel
Accession Mass Score1 Protein Master2
Volume ratio
(Cy3/Cy5)
% MS ‘‘visible’’
peptides3
gi|5032057 1,1847 62 S100 calcium-binding protein A11 2,705 2.0 90
gi|7245516 9,968 105 pinLC8 2,654 2.0 85
gi|239552 44,564 212 Squamous cell carcinoma antigen 1,947 4.5 65
gi|2118384 45,044 147 Squamous cell carcinoma antigen-2 (leupin) 1,953 5.1 60
gi|239552 44,564 138 Squamous cell carcinoma antigen 1,976 4.2 45
gi|62896815 53,580 86 Heat-shock 70-kDa protein 1,408 4.7 25
Cy, cyanin; MS, mass spectrometry.
1Mascot search engine score based on probability implementation of the MOWSE algorithm.
2Corresponds to spot numbers in Figure 1.
3Percentage of identified peptides between 600 and 4,000Da.
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Figure 2. Calcium-induced S100/A11 expression is inhibited by IL-4 and IL-13. Keratinocytes were cultured in Ca2þ -rich environments in the presence
and absence of IL-4 (100 ngml1) and IL-13 (100 ngml1). S100/A11 expression was evaluated using real-time RT-PCR and western blot technology in
HaCaT cells ((a) and (b), respectively) and real time RT-PCR in NHK (c). Columns and error bars represent mean±SEM.
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0.43±0.05; FLG: 0.002±0.0003). This induction was
significantly (Po0.001) inhibited by the presence of IL-4
and IL-13 (Figure 4a). Similar results were observed in the
more physiologically relevant NHKs (Figure 4b). Using
western blots, we confirmed that IL-4 and IL-13 down-
regulate FLG and the precursor, pro- FLG (Figure 4c).
To determine whether S100/A11 is the key mediator of
calcium induced HBD-3 and keratinocyte differentiation, we
used small interfering RNA (siRNA) to inhibit S100/A11 gene
expression (Figure 5a). HaCaT cells were transfected with
either control siRNA or S100/A11 siRNA, followed by
incubation with low (1.5mM) and high (10mM) CaCl2.
Calcium-mediated induction of HBD-3 and FLG was
significantly inhibited in HaCaT cells transfected with S100/
A11 siRNA (HBD-3: 0.29±0.08 ng HBD-3 per ng GAPDH;
Po0.001; FLG: 0.002±0.001 ng FLG per ng GAPDH;
Po0.001) as compared with cells transfected with control
siRNA (HBD-3: 5.14±0.52 ng HBD-3 per nanogram of
GAPDH; FLG: 0.016±0.001 ng FLG per nanogram of
GAPDH) (Figure 5b). Since the expression of loricrin and
involucrin have previously been shown to be inhibited by
Th2 cytokines (Kim et al., 2007b), we also examined
expression of these two epidermal skin barrier proteins.
Interestingly, loricrin and involucrin expression were not
significantly modulated by the inhibition of S100/A11 (data
not shown), suggesting that S100/A11 did not have a global
effect on epidermal differentiation.
Requirement for p21 in cell differentiation and host defense
p21 is a downstream target of calcium and S100/A11.
Furthermore, it is transcriptionally activated to induce growth
arrest by halting the cell cycle in the G1 phase (Hrebicek
et al., 2007). Importantly, we found that p21 gene expression
is significantly decreased in acute AD (0.08±0.02 ng p21
per nanogram of GAPDH; Po0.001) and to a lesser
extent chronic AD (1.13±0.34) as compared to normal
(5.96±0.76) and psoriasis (5.67±0.51) skin biopsies
(Figure 6a). These data support a physiologic link between
S100 and p21 in AD. To study this phenomenon in more
molecular detail, we treated keratinocytes with high CaCl2
(10mM) and found that they were unable to induce p21
protein expression in the presence of IL-4 and IL-13 (Figure
6b). Therefore, we investigated whether p21 is an integral
part of the calcium-mediated induction of HBD-3 and FLG
expression.
HaCaT cells were transfected with either control siRNA or
p21 siRNA and then incubated with low (1.5mM) versus high
(10mM) CaCl2 cells incubated with p21 siRNA had significant
lower levels of p21 protein expression as compared with a
control siRNA (Figure 7a). Despite the increase in CaCl2, cells
transfected with p21 siRNA failed to express HBD-3
(0.33±0.07 ng HBD-3 per nanogram of GAPDH) and FLG
(0.001±0.001 ng FLG per nanogram of GAPDH) (Figure 7b).
Since p21 is downstream of S100/A11 (Figure 7a), and
also necessary for the induction of HBD-3 and FLG, we
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Figure 3. S100/A11 deficiency in AD skin. (a) RNA was isolated from the skin of normal subjects (n¼ 11), AD patients with acute lesions (n¼ 12),
AD patients with chronic lesions (n¼ 9), or psoriasis (n¼12). S100/A11 gene expression was evaluated using real-time RT-PCR. (b) Representative skin
sections from normal subjects (n¼6), AD patients with acute lesions (n¼ 6), AD patients with chronic lesions (n¼6), or psoriasis (n¼ 5) immuno-stained for
S100/A11 are shown. Images were collected at original magnification  40. (c) The intensity of immunostaining was graded visually on a scale from 0
(no staining) to 5 (the most intense staining).
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investigated whether cells over expressing p21 protein could
induce HBD-3 and FLG in the presence of IL-4 and IL-13. A
recombinant p21 protein was delivered to HaCaT cells using
a BioTrek protein delivery kit (Figure 8a). Cells were then
cultured in the presence and absence of IL-4 and IL-13 for 24
hours. Delivery of p21 recombinant protein to keratinocytes
significantly induced HBD-3 (7.15±1.20 ng HBD-3 per
nanogram of GAPDH; Po0.001) and FLG (0.017±0.002 ng
FLG per nanogram of GAPDH) expression as compared to
cells, which had a mock protein (HBD-3; 0.40±0.09, FLG;
0.001±0.001). In Figure 5b, we show that IL-4 and IL-13 are
able to inhibit the induction of HBD-3 and FLG. However,
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Figure 5. S100/A11 is required for calcium-induced HBD-3 and FLG expression. Keratinocytes were cultured in Ca2þ -rich environments in the presence
and absence of S100/A11 siRNA. (a) S100/A11 protein expression was evaluated using western blot. Results of a representative experiment (n¼4)
are shown. (b) HBD-3 and FLG gene expression were analyzed by real time RT-PCR. Columns and error bars represent mean±SEM.
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Figure 4. IL-4 and IL-13 inhibit Ca2þ -induced HBD-3 and FLG expression. HaCaT cells (a) and NHK (b, c) were cultured in a Ca2þ rich environment
in the presence and absence of IL-4 and IL-13. RNA (a, b) was isolated from the cells and analyzed for HBD-3 and FLG using real-time RT-PCR. Columns
and error bars represent the mean±SEM. Protein was isolated and then analyzed by Western blot analysis (c) for proFLG and FLG.
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delivery of p21 recombinant protein to HaCaT cells
prevented the ability of IL-4 and IL-13 to inhibit HBD-3 and
FLG expression (Figure 8b).
DISCUSSION
The epidermal skin barrier serves as the first line of defense
against invading pathogens and allergens. The skin of AD
patients is characterized by significant barrier disruption,
which increases susceptibility to allergic sensitization, as well
as recurrent bacterial and viral skin infections (Leung et al.,
2004; Cork et al., 2006). Recent studies have shown that the
Th2 cytokine milieu in AD skin plays an important role in
downregulating skin barrier function and host defense (Ong
et al., 2002; Howell et al., 2006a, b, 2007a, b). The
mechanisms, however, underlying these observations are
unknown. Therefore, the current study used a hypothesis-free
approach to investigate the global effects of IL-4 and IL-13 on
protein expression in keratinocytes. Using proteomic tech-
nology, we focused our attention on proteins, which had a
greater than two-fold absolute change in expression. As
shown in Table 1, significant increases in protein levels were
observed for squamous cell carcinoma antigen (SCCA),
SCCA2 (leupin), and heat-shock protein 70 kDa, whereas
decreased protein levels were found for PIN/LC8, and S100
calcium-binding protein A11 (S100/A11).
SCCA1 (SERPINB3) and SCCA2 (SERPINB4) are members
of the ovalbumin–serpin proteinase inhibitor family (B clade)
that fold into unique structures to inhibit serine and cysteine
proteinases (Silverman et al., 2001). These proteins have
previously been shown to be upregulated in the skin of AD
patients (Mitsuishi et al., 2005) and serum of acute asthmatics
(Nishi et al., 2005). Consistent with our current observations,
IL-4 and IL-13 have been previously reported to induce SCCA
expression in keratinocytes (Mitsuishi et al., 2005). Heat-
shock proteins are induced by environmental (that is, heat
shock) and physiological (that is, inflammation) stress in order
to protect cells. These proteins are constitutively expressed in
normal skin and serve as chaperones by stabilizing unfolded
proteins for transport across cellular membranes (Schlesinger,
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1990; Maytin, 1995). Heat-shock protein-70 proteins have
also been previously reported to have increased expression in
the skin of AD patients with highest expression observed in
those individuals with severe AD (Ghoreishi et al., 2000).
PIN/LC8 is an 8-kDa dynein light chain that plays a role in
intracellular protein trafficking (Liang et al., 1999). McCauley
et al. (2007) recently demonstrated that PIN/LC8 binds to
neuronal nitric oxide synthase and inhibits nitric oxide
production in mast cells. Additionally, it was suggested that
this interference is responsible for blocking leukotriene
production. On the basis of lack of novelty and their
likelihood of a functional role in AD, we chose not to pursue
the role of SCCA, SCCA2 (leupin), heat-shock protein-70, and
PIN/LC8 as targets for Th2 cytokine inhibition of HBD-3
and FLG.
S100/A11 (calgizzarin) is a member of the EF-hand Ca2þ -
binding family that is activated by increased Ca2þ concen-
trations and interferes with Ca2þ -signaling pathways by
binding to and regulating target proteins (Unlu et al., 1997).
Calcium-sensor target proteins have been identified, which
impact protein phosphorylation, cell growth, motility, and
cell survival (Unlu et al., 1997; Hrebicek et al., 2007).
Robinson et al. (1997) initially identified S100/A11 as an
important component of the cornified envelope in the skin.
The epidermal barrier, including the cornified envelope,
serves as the first line of defense against invading pathogens
and allergens. Recently there has been an interest in
understanding the role of the epidermal differentiation
complex in AD. S100/A11 is encoded within the same
region of the epidermal differentiation complex on chromo-
some 1q21 (Eckert et al., 2004). Combined with our
proteomic data, which confidently (90% sequence matching)
showed that IL-4 and IL-13 down regulates S100/A11
expression, we therefore investigated the role of S100/A11
on skin barrier integrity and innate host defense.
To our knowledge, this is the first demonstration that S100/
A11 is down-regulated by the Th2 cytokines, IL-4 and IL-13.
Additionally, we demonstrate that S100/A11 is decreased in
the skin of AD patients. Since S100/A11 is an important
component of the epidermal differentiation complex, this
may explain, in part, the significant acquired barrier
dysfunction observed in AD skin. To further understand the
role of S100/A11, we investigated the immunomodulatory
effect of S100/A11 on FLG and HBD-3. These proteins have
been shown to be integral in maintaining an intact skin
barrier (Howell et al., 2007a) and protecting against invading
pathogens due to potent anti-viral and anti-bacterial activity
(Harder et al., 2001; Howell et al., 2007b), respectively.
Therefore, we first demonstrated that culturing NHK and the
immortalized HaCaT keratinocyte cell line in the presence of
increased calcium significantly induced S100/A11, FLG and
HBD-3 expression. Inhibiting S100/A11 gene transcription
using siRNA, however, prevented the Ca2þ -mediated induc-
tion of FLG and HBD-3. This observation is significant since
FLG deficiency has been recently linked to severe AD
(Palmer et al., 2006; Weidinger et al., 2006; Sandilands
et al., 2007) and progression of the atopic march leading to
the development of asthma. Additionally, the down-regula-
tion of HBD-3 increases the susceptibility of individuals to
recurrent skin infections with bacterial and viral pathogens
(Harder et al., 2001; Howell et al., 2007b).
S100 proteins bind to target proteins to regulate Ca2þ -
signaling pathways. p21 (WAF1) is a cyclin-dependent kinase
inhibitor downstream of S100/A11 that is involved in the cell
growth and differentiation (Weinberg and Denning, 2002;
Sakaguchi et al., 2005). Therefore, we further investigated the
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role of p21 in our experimental system. We first investigated
the relationship between p21 and S100/A11. While increased
Ca2þ concentrations induced p21 protein expression, this
was inhibited by interfering with S100/A11 using siRNA.
Similarly, the addition of IL-4 and IL-13 inhibited p21
expression in keratinocytes cultured in high Ca2þ concen-
trations. As a result, we investigated the effects of p21 on FLG
and HBD-3. To do this, we inhibited p21 mRNA using siRNA
and then cultured keratinocytes in the presence of increased
Ca2þ to induce FLG and HBD-3. Ca2þ mediated induction
of FLG and HBD-3 was inhibited by interfering with p21
expression, suggesting an important role for p21 in the
regulation of the barrier integrity and host defense. This
observation was further supported by transducing keratino-
cytes with recombinant p21 protein and demonstrating
increased FLG and HBD-3 expression without the addition
of high Ca2þ concentrations. Additionally, IL-4 and IL-13
failed to inhibit the induction of FLG and HBD-3 in p21
protein-transduced keratinocytes.
Our current study therefore demonstrates that S100/A11
and p21 are decreased in the skin of AD patients and that IL-4
and IL-13, previously reported to be increased in AD, can
downregulate S100/A11 and p21. Furthermore, we demon-
strate that S100/A11 and p21 play an important role in
regulating the expression of FLG and HBD-3. This may
contribute to the significant barrier disruption and AMP
deficiency observed in the skin of AD patients. Importantly, it
identifies novel targets to enhance keratinocyte differentia-
tion and skin innate immune responses in this common skin
disease.
MATERIALS AND METHODS
Subjects
The subjects included 12 healthy persons with no history of skin
disease (mean age: 29.8±3.8 years), 21 patients with mild-to-
moderate AD (mean age: 34.7±3.4 years), and 12 patients with
psoriasis (mean age: 52.1±4.8 years). None of the patients had
received systemic corticosteroids or cyclosporine previously, and
none had received topical corticosteroid or calcineurin inhibitors for
a period of at least 1 week before enrollment. These studies were
conducted according to the Declaration of the Helsinki Principles
and were approved by the institutional review board at National
Jewish Medical and Research Center in Denver and all subjects gave
written informed consent prior to participation in these studies.
Two-millimeter punch biopsies were collected from the acute
lesional skin of 12 AD subjects, chronic lesional skin of nine AD
patients, lesional skin of 12 psoriasis subjects, and healthy skin from
12 normal subjects. Skin samples were submerged immediately in
either Tri-Reagent (Molecular Research Center Inc., Cincinnati, OH)
or 10% buffered formalin for real-time RT-PCR and immunohisto-
chemical studies, respectively.
Keratinocyte cultures
The HaCaT human keratinocyte cell line was grown in Dulbecco’s
modified Eagle’s Medium (Cellgro, Herndon, VA) as previously
described (Howell et al., 2006a). Cells were seeded at
2 105 cellsml1 and allowed to adhere for 18–24 hours prior to
stimulation. HaCaT cells were then stimulated with 100 ngml1 of
IL-4 (R&D Systems, Minneapolis, MN) and 100 ngml1 of IL-13
(R&D Systems) for 24 hours. Following the initial 24-h incubation,
the concentration of calcium chloride (CaCl2) was increased to
10mM, cytokines were refreshed, and cells were cultured for an
additional 24 hours.
Primary keratinocyte cell cultures (NHK) were obtained from
Cascade Biologics (Portland, OR) and maintained in serum free
EpiLife Medium (Cascade Biologics) containing 0.06mM CaCl2 as
previously described (Kim et al., 2007a). In some experiments, NHK
cells were differentiated in 1.3mM CaCl2 and stimulated with
100 ngml1 of IL-4 (R&D Systems) and 100ngml1 of IL-13 (R&D
Systems) for 5 days.
Proteomics
The differential in gel electrophoresis was used to determine the
protein composition of human keratinocytes. Proteins were pre-
cipitated from the cell culture lysate using a methanol/chloroform
extraction method previously described (Wessel and Flugge, 1984).
Precipitated protein pellets were then dissolved overnight in 7M
urea, 2 M thiourea, 4% w/v 3-[(3-cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate at room temperature. The final
protein concentration was determined using Bradford method
(Bradford, 1976).
Differential in gel electrophoresis covalent labeling with
CyDyes
For each sample, 50mg of total protein was covalently modified
with one of the CyDyes (Amersham Biosciences, Piscataway, NJ).
The pH was adjusted by addition of pH 8.5 Tris to a final
concentration of 30mM. The CyDye (1ml, 200 pmol ml1 in
anhydrous dimethylformamide (Sigma-Aldrich, St Louis, MO)) was
added to the protein and the reaction allowed to proceed
(30minutes, 4 1C, in the dark). Under these conditions approxi-
mately 1% of the lysine residues of the protein sample are covalently
conjugated to the CyDye). The reaction was then quenched by the
addition of 10 nM of lysine. After the dye reactions were complete,
the labeled samples were combined to one tube and an additional
450mg of unlabeled protein from each of the two samples (1,000 mg
total) was added to facilitate protein identifications after electro-
phoresis. Pharmalytes (Amersham Biosciences) and saturated aqu-
eous bromophenol blue (1 ml) were added. The samples were
brought to a final volume of 450 ml with a composition of 7M urea,
2 M thiourea, 4% w/v 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate, 2% broad range Pharmalytes (3-10 NL) and 2%
dithiothreitol.
Two-dimensional gel electrophoresis. After resuspension in the
rehydration buffer, protein samples were passively rehydrated into
24-cm immobilized pH gradient strips (IPG 3-10 NL; Amersham
Biosciences) for 15 hours and then focused (IPGPhor system;
Amersham Biosciences) for at least 133,000 volt-hours. Two-
dimensional gel electrophoresis was carried out as previously
described (McDermott et al., 2007).
Scanning of differential in gel electrophoresis-labeled
images. Gels were scanned on a Typhoon 9400 Variable Mode
Laser Imager (Amersham Biosciences) set to 100-mm resolution.
Laser and filter settings were as follows: Cy3, excitation 532 nm,
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emission 580 nm, bandpass 30 nm; Cy5, excitation 633 nm, emis-
sion 670 nm, bandpass 30 nm; and Cy2, excitation 488 nm, emission
582 nm, bandpass 40 nm. The preparative gel used for protein spot
excision was stained with Deep Purple Dye (Amersham Biosciences)
to assess any mass shift between CyDye-labeled and unlabeled
protein that occurs at low molecular weight.
Image analysis. DeCyder software (v. 6.5; Amersham Biosciences)
was used for spot detection and relative quantification of proteins
based on the fluorescent images. Peak volumes were measured for
each protein spot in the three fluorescent channels (Cy3, Cy5 and
Cy2). Volume ratios were calculated to directly compare volumes of
each protein spot between the two directly compared samples.
Proteins to be excised and identified were selected using the
DeCyder Differential In-gel Analysis Module if the volume ratio
difference was 42.0.
Spot selection and enzymatic digestion. Protein spot excision
and in-gel enzymatic digestion were performed automatically by the
Ettan Spot Handling Workstation (Amersham Biosciences) as
described previously (McDermott et al., 2007).
Protein identification by mass spectrometry. All digests were
analyzed by Matrix-Assisted Laser Desorption/Ionization Time-of-
Flight MS (Voyager DE-STR; Applied Biosystems, Foster City, CA).
After trypsin digestion, an aliquot (0.7 ml) of each sample was
deposited on a standard stainless steel 100-well Matrix-Assisted
Laser Desorption target (Applied Biosystems). Agilent a-Cyano-4-
hydroxycinnamic acid solution was used as the matrix (Agilent, Palo
Alto, CA) and added to the sample on target (0.7 ml). Spectra were
collected over the range m/z 500–5,000 in positive ion mode using
the instruments full reflector flight path. No cleanup of digests was
performed. Peptide mass fingerprints were internally calibrated to
monoisotopic trypsin autolysis peaks (m/z¼ 515.33, 842.51,
1,045.56, 2,211.11). Spectra were processed using ProTS Data
(Efeckta Technologies, Steamboat Springs, CO) to generate cen-
troided peak lists that were submitted to Mascot (Matrix Sciences,
Boston, MA) for database searching. Spectral processing included
defining baseline, noise, and signal-to-noise ratio as well as
monoisotopic peak selection. A signal-to-noise ratio in ProTS data
of44 was required for inclusion in the peak list. Database searches
were conducted using a human subset (153,190 sequences) of the
non-redundant protein database (NCBI, database version 11/04/
2006 with 4,099,826 sequences and 1,413,990,101 residues). Other
settings in ProTS included peak amplitude set at 100, peak width
250, and chemical noise factor 1.5. Key Mascot parameters included
the following: peptide error tolerance was set at ±30 p.p.m., fixed
modification of carbamidomethylation of cysteine side chains, and
trypsin selected as the enzyme for peptide cleavage with one missed
cleavage accepted. Searches were not constrained by pI or
molecular weight. Tandem mass spectrometry was performed on a
LC/MSD XCT ion-trap mass spectrometer (Agilent). A total of 5ml of
digest solution was injected onto a c18 trapping column. The LC
system (Agilent nanoflow 1100) was used to elute peptides off of the
trap and through a heated 75-mm c18 column with a gradient of
increasing acetonitrile. MS/MS spectra were collected in a software-
driven data-dependent analysis. Spectra were processed and
analyzed using Spectrum Mill (Agilent).
RNA isolation and analysis
Total RNA was isolated from 2-mm skin biopsy samples using Tri-
Reagent according to the manufacturer’s guidelines (Molecular
Research Center Inc.). RNeasy Mini Kits (Qiagen, Valencia, CA)
were used according to the manufacturer’s protocol to isolate RNA
from cell cultures and to further purify RNA from skin biopsies. RNA
was reverse transcribed into cDNA and analyzed by real-time
RT-PCR as previously described (Nomura et al., 2003b). Primers and
probes for GAPDH, S100(A11), p21, involucrin, loricrin, and FLG
were purchased from Applied Biosystems. HBD-3 primers and
probes were prepared as previously described (Nomura et al.,
2003b). Relative expression levels were determined as outlined in
the manufacturer’s technical bulletin (Applied Biosystems). To allow
for comparisons between samples and groups, target gene expres-
sion was normalized to the corresponding GAPDH levels.
Transient and stable transfectants
HaCat cells were transiently transfected at 60% confluency with
100 nM of S100/A11 (Dharmacon, Lafayette, CO), p21 siRNA
(AM51326; Ambion Inc., Austin, TX), or control siRNA (4611;
Ambion, Inc.), using Lipofectamine 2000 according to the manu-
facturer’s guidelines (Invitrogen, Carlsbad, CA). The sequence
targeting human S100/A11 was as follows: sense, 50-CAACAGUG
AUGGUCAGCU AUUtt-30; antisense, 50-UAGCUGACCAUCACUG
UUGUUtt-30. The sequence targeting human p21 was as follows:
sense, 50-GGAGUCAGACAUUUUAAGAtt-30; antisense, 50-UCUUA
AAAUGUCUGACUCCtt-30. In order to estimate the efficiency of
transfection, siRNA was labeled with Cy3 on the 50 end of the
antisense sequence.
The recombinant p21 protein was introduced into cells using a
BioTrek Protein Delivery kit (204140; Stratagene, La Jolla, CA). The
p21 (908-281; Assay Designs, Ann Arbor, MI) protein and an FITC-
antibody control protein were delivered into HaCaT cells (60%
confluent) according to the manufacturer’s guidelines (Stratagene).
Four hours following protein delivery, the media was changed and
the delivery efficiency was determined using fluorescent imaging.
The protein delivery efficiency was approximately 80% for each
experiment. The p21-transfected cells were then treated with low
calcium plus or minus IL-4 and IL-13 and harvested after 24 hours for
immunoblotting and real-time analysis.
Western blot analysis
Protein extracts were prepared by lysing the cells in radioimmuno-
precipitation assay buffer (1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS in phosphate-buffered saline) containing protease and
phosphatase inhibitors. Proteins were electrophoresed using NuPage
and transferred to a polyvinylidene fluoride membrane. Membranes
were then blocked with 5% non-fat milk and probed with antibodies
against anti-p21 (sc-817; Santa Cruz Biotechnology, Santa Cruz,
CA), anti-S100A11 (BC001410; Proteintech Group Inc., Chicago, IL),
and anti-b-tubulin (32–2600; Zymed, San Francisco, CA). Mem-
branes were incubated with secondary Ig antibodies conjugated to
horseradish peroxidase and developed using the enhanced
chemiluminescence plus detection system (Amersham Biosciences,
Little Chalfont Buckinghamshire, England, UK) followed by
autoradiography.
To visualize proFLG and FLG, 20 mg of total proteins were
resolved under reducing conditions by 10% of SDS–polyacrylamide
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gel (Bio-Rad, Hercules, CA) electrophoresis and transferred to
reinforced nitrocellulose membrane (Bio-Rad). The membrane was
blocked with 5% nonfat dry milk in Tris-buffered saline at 4 1C for
overnight. After blocking the membrane was incubated for 2 hours at
room temperature with anti-FLG mouse monoclonal antibody
diluted 1:100 (Vector Laboratories Inc., Burlingame, CA) in 1%
BSA/0.06% Tween 20 in Tris-buffered saline. The membrane was
washed three times using Tris-buffered saline with 0.2% Tween 20
for 10minutes each and then incubated with anti-mouse horseradish
peroxidase-conjugated secondary antibody (Amersham Biosciences)
at dilution of 1:10,000 in 1% bovine serum albumin/0.06% Tween
20 in Tris-buffered saline for 1 hour at room temperature. The
membrane was washed three times for 10minutes each using
Tris-buffered saline with 0.2% Tween 20 and then developed with
enhanced chemiluminescence Western Blotting Detection Reagents
(Amersham Biosciences) according to the manufacturer’s protocol.
Immunohistochemistry
Two-millimeter skin biopsies were paraffin embedded and cut into
5-mm sections. Tissue samples were deparaffinized through a series
of ethanol washes and then incubated with either a polyclonal rabbit
anti-S100A11 (BC001410; Proteintech Group Inc.) antibody over-
night. The cell and tissue staining kit for mouse and rabbit primary
antibodies (R&D Systems) was used according to the manufacturer’s
protocol. Antibody specificity was confirmed using purified non-
immune mouse or rabbit IgG (Southern Biotechnology, Birmingham,
AL). All slides were coded prior to analysis and read blindly, to
ensure patient anonymity. The intensity of the immunostaining was
graded with the use of microscopy on a scale from 0 to 5, with 0
indicating no staining and 5 the most intense staining.
Statistical analysis
Statistical analysis was conducted using Graph Pad Prism, version
4.03 (San Diego, CA). Data were analyzed by a one-way analysis of
variance and significant differences were determined by Tukey–
Kramer test (Tukey, 1977). Differences were considered significant
at Pp0.05. A minimum of three independent experiments were
conducted to allow for statistical comparison.
For statistical analysis of the Matrix-Assisted Laser Desorption/
Ionization Time-of-Flight mass fingerprint results Mascot, version 2.1
(Matrix Sciences) was used to calculate a probability-based score.
This software uses a probability-based implementation of the Mowse
algorithm (Pappin et al., 1993). The Mascot score is the absolute
probability that the observed match is a random event and is
reported as 10log10(P), where P is absolute probability.
DeCyder, version 6.0 (GE Healthcare), differential analysis
software, was used for automatic spot detection (co-detection
algorithm), background subtraction, quantitation, normalization,
and inter-gel matching of the fluorescent images. An internal
standard, which consisted of pools of treated and untreated samples,
was combined and labeled with Cy2. This internal standard was
used to calculate standardized volume ratios using the biological
variation analysis Module. Protein spot volume ratios were
compared using a Student’s t-test (two-tailed) in the biological
variation analysis module.
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